NASDAQEquity ยท Daily Price and Trend

PCSA

Processa Pharmaceuticals Inc

US Healthcare Biotechnology

52-week price-80.1%
Latest week
9 Oct 2026
Weekly close
1.52 USD
Fair value
36.47 USD
Next-week expectancy
Negative 42.19%

Current NASDAQ session

Delayed price and five-minute path

Loading daily pricesโ€ฆ Preparing todayโ€™s five-minute path
Last price โ€”

โ€”

โ€”
Open
โ€”โ€”
High
โ€”โ€”
Low
โ€”โ€”
Previous close
โ€”Daily reference
Volume
โ€”Session to date
Todayโ€™s five-minute path
09:30โ€“16:00 EDT
Delayed market data. The chart shows five-minute prices from market open. Last updated โ€”
Weekly anchor9 October 2026
Daily period12 Octโ€“12 Oct 2026
Completed sessions1

A new perspective begins when the next completed weekly update is published.

Price and trend

Price has advanced the latest weekly close

The daily path has softened without yet producing a decisive structural break.

Being tested since the weekly update

Move since weekly update

+25.00%

Latest completed daily close versus 1.52 USD.

Weekly view

Being tested

The daily path has softened without yet producing a decisive structural break.

Current position

Above the weekly close

Price location against the completed weekly reference points.

Participation

28.7ร— recent

Trading participation has been stronger than the recent completed record.

Path quality

Developing

More completed sessions are needed to judge the shape of this weekโ€™s path.

Latest session

1.90

Firm advance

Price since the weekly update

How the daily path is developing

Completed sessions only. The shaded area begins after the weekly anchor.

Up session Down session Current perspective Weekly closeTrend referenceCompleted supportCompleted resistance

Daily summary

What price and participation show

What supports it

Being tested

The daily path has softened without yet producing a decisive structural break.

What has changed

+25.00% since the update

The period has produced 1 completed session.

What could weaken it

Loss of completed support

A sustained move beneath completed support would materially weaken the developing position.

What to watch next

Above the weekly close; developing path

The next completed session will show whether price and participation reinforce or challenge the current direction.

Session progression

What happened each day

  1. AdvancedClosed near the session high
    1.90+25.00%

Other market evidence

What else has changed

Latest stored top-level readings; badges identify evidence updated since the weekly anchor.

Short interest

Neutral

PCSA is classified as Neutral. Latest reported short interest is 4.1K shares; short interest changed -72.4%, price moved -11.5% between the weekly closes on or before the two settlements, short shares rank 0/100 within the comparable stored history, and days to cover ranks 12/100 within that history. Trend context is improving.Open short interest โ†’

Evidence context